Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Antônio da Silva
Observed names:
Antonio Da Silva,
Antonio da Silva,
Silva, Antonio Da,
Silva, Antonio da
Institution:
Wrexham Maelor Hospital
Observed institutions:
Harvard University,
Universidade de São Paulo,
Wrexham Maelor Hospital,
Hexal (Germany),
Hospital de Câncer de Barretos,
Dana-Farber Cancer Institute,
Grupo Hospitalar Conceição,
Universidade Federal de São Paulo,
Pontifícia Universidade Católica de São Paulo
show all 9
OpenAlex ID:
A5103755783
A importância da atuação odontológica em pacientes internados em unidade de terapia intensiva
2006
·
Teresa Márcia Nascimento de Morais
, Antonio da Silva
, et al.
·
Revista Brasileira de Terapia Intensiva
·
167
PDF
Eradication of Tumors from a Human Colon Cancer Cell Line and from Ovarian Cancer Metastases in Immunodeficient Mice by a Single-Chain Ep-CAM-/CD3-Bispecific Antibody Construct
2005
·
Bernd Schlereth
, Iduna Fichtner
, et al.
·
Cancer Research
·
146
FYN-T-FYB-SLP-76 Interactions Define a T-cell Receptor ζ/CD3-mediated Tyrosine Phosphorylation Pathway That Up-regulates Interleukin 2 Transcription in T-cells
1999
·
Monika Raab
, Hyun Kang
, et al.
·
Journal of Biological Chemistry
·
108
src-related protein tyrosine kinases and their surface receptors
1993
·
Christopher E. Rudd
, Ottmar Janssen
, et al.
·
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
·
92
Pharmacological Trials of Crude Extract ofPassiflora alata
1984
·
Seizi Oga
, Paulo de Freitas
, et al.
·
Planta Medica
·
71
Potent inhibition of local and disseminated tumor growth in immunocompetent mouse models by a bispecific antibody construct specific for Murine CD3
2005
·
Bernd Schlereth
, Petra Kleindienst
, et al.
·
Cancer Immunology Immunotherapy
·
61
Target-directed development and preclinical characterization of the proposed biosimilar rituximab GP2013
2013
·
Antonio da Silva
, Ulrich Kronthaler
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
46
PDF
Waiving in vivo studies for monoclonal antibody biosimilar development: National and global challenges
2016
·
Kathryn Chapman
, Akosua Adjei
, et al.
·
mAbs
·
41
Characterization and non-clinical assessment of the proposed etanercept biosimilar GP2015 with originator etanercept (Enbrel®)
2016
·
Hans-Peter Hofmann
, Ulrich Kronthaler
, et al.
·
Expert Opinion on Biological Therapy
·
35
PDF
Comparative functional and pharmacological characterization of Sandoz proposed biosimilar adalimumab (GP2017): rationale for extrapolation across indications
2018
·
Ulrich Kronthaler
, Cornelius Fritsch
, et al.
·
Expert Opinion on Biological Therapy
·
30
Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts
2021
·
Imran Mohamed
, Mohamad Fathul Aizat Kamarizan
, et al.
·
Cochrane Database of Systematic Reviews
·
27
Reinfection in a large cohort of prison inmates with sustained virological response after treatment of chronic hepatitis C in Catalonia (Spain), 2002–2016
2019
·
Andrés Marco
, Rafael A. Guerrero
, et al.
·
International Journal of Drug Policy
·
20
Human CD4/CD45RA+ and CD4/CD45RA− T cell subsets express CD4-p56lck complexes, CD4-associated lipid kinases, TCR/CD3-p59fyn complexes, and share similar tyrosine kinase substrates
1993
·
David M. Rothstein
, Antonio da Silva
, et al.
·
International Immunology
·
17
Exchanging human Fcγ1 with murine Fcγ2a highly potentiates anti-tumor activity of anti-EpCAM antibody adecatumumab in a syngeneic mouse lung metastasis model
2006
·
Petra Lutterbuese
, Klaus Brischwein
, et al.
·
Cancer Immunology Immunotherapy
·
16
Scientific Rationale Underpinning the Development of Biosimilar Rituximab in Hematological Cancers and Inflammatory Diseases
2019
·
Wojciech Jurczak
, Stanley Cohen
, et al.
·
Future Oncology
·
11
PDF
The Influence of Whole-Body Vibration on Creatine Kinase Activity and Jumping Performance in Young Basketball Players
2013
·
Rafael Fachina
, Antônio da Silva
, et al.
·
Research Quarterly for Exercise and Sport
·
8
Role of Pharmacokinetics: Pharmacodynamics in Biosimilar Assessment
2016
·
Antonio da Silva
, Didier Renard
·
Springer eBooks
·
4
Target-Directed Development of a Proposed Biosimilar Rituximab (GP2013): Comparability of Antibody-Dependent Cellular Cytotoxicity Activity and Pre-Clinical Pharmacokinetics and Pharmacodynamics with Originator Rituximab
2012
·
Antonio da Silva
, Ulrich Kronthaler
, et al.
·
Blood
·
4
Physicochemical, functional, and pharmacologic comparability between the proposed biosimilar rituximab GP2013 and originator rituximab as the foundation for biosimilarity.
2013
·
Antonio da Silva
, Ulrich Kronthaler
, et al.
·
Journal of Clinical Oncology
·
3
Spontaneous splenic rupture in the postpartum period
2008
·
Sharath CV Paravastu
, Anthony Burdge
, et al.
·
British Journal of Hospital Medicine
·
2
Non-clinical Pharmacological Characterization and In-Vivo Efficacy of the Proposed Adalimumab Biosimilar GP2017 Compared to the Originator Adalimumab
2016
·
Antonio da Silva
, Cornelius Fritsch
, et al.
·
The American Journal of Gastroenterology
·
1
Doctor, What Should I Do About My Iliac Aneurysm, Could Artificial Intelligence Help?
2024
·
Antonio Da Silva
, Sanjay Agarwal
·
EJVES Vascular Forum
The Use of Angioscopy in Vascular Access Surgery: Shedding New Light
2019
·
Mohamad Kamarizan
, Antonio Da Silva
·
European Journal of Vascular and Endovascular Surgery
Nonclinical Pharmacological Characterization and in Vivo Efficacy of the Proposed Adalimumab Biosimilar Gp2017 Compared to the Originator Adalimumab
2016
·
Antonio da Silva
Evolutive assessment of endothelial function in metabolic control and microvascular complications in type 1 diabetes mellitus patients
2015
·
Winston Boff
, Antonio da Silva
, et al.
·
Diabetology & Metabolic Syndrome
PDF
Show more works
View as search
Works count:
29
Citation count:
910
H-index:
14
I10-index:
15
Year
Topic
Type